| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |